Some good news in our race for a COVID-19 vaccine. Both Johnson & Johnson and Astrazeneca have announced they’re resuming phase 3 trials for their respective COVID vaccines.
AstraZeneca has resumed the U.S. trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & Johnson is preparing to resume its trial early next week, the companies said on..
![COVID-19 vaccine trial progressing with help from Valley participants [Video]](https://video.newsserve.net/300/v/20201031/2010310553-COVID-19-vaccine-trial-progressing-with-help-from.jpg)
![Daily Covid-19 Minute: Astrazeneca’s Vaccine Trial Has Been On Pause For 6 Weeks, Here’s What We Know [Video]](https://video.newsserve.net/300/v/20201027/2010271317-Daily-Covid-19-Minute-Astrazeneca-Vaccine-Trial.jpg)
![J&J, AstraZeneca resuming trials of vaccines [Video]](https://video.newsserve.net/300/v/20201024/2010242041-AstraZeneca-resuming-trials-of-vaccines.jpg)
